Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This was an open-label study to provide an opportunity for participants with Ulcerative
Colitis (UC) who previously completed Study C13002 (NCT01177228), and for treatment-naïve
participants with UC or Crohn's Disease (CD) to receive treatment with vedolizumab, and to
determine the long term safety of vedolizumab in patients afflicted with these diseases.